Penson RT - Search Results

1

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer.

McGuire WP, Penson RT, Gore M, Herraez AC, Peterson P, Shahir A, Ilaria R Jr. McGuire WP, et al. Among authors: penson rt. BMC Cancer. 2018 Dec 27;18(1):1292. doi: 10.1186/s12885-018-5198-4. BMC Cancer. 2018. PMID: 30591028 Free PMC article. Clinical Trial.

2

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

Gore ME, Rustin G, Slevin M, Gallagher C, Penson R, Osborne R, Ledermann J, Cameron T, Thompson JM. Gore ME, et al. Br J Cancer. 1997;75(5):710-4. doi: 10.1038/bjc.1997.126. Br J Cancer. 1997. PMID: 9043029 Free PMC article. Clinical Trial.

3

Ovarian cancer: an update on genetics and therapy.

Penson RT, Shannon KE, Sharpless NE, Seiden MV. Penson RT, et al. Compr Ther. 1998 Oct;24(10):477-87. Compr Ther. 1998. PMID: 9801846 Review.

4

A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.

Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV. Duska LR, et al. Clin Cancer Res. 1999 Jun;5(6):1299-305. Clin Cancer Res. 1999. PMID: 10389912 Clinical Trial.

5

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A, Seiden MV. Campos SM, et al. Among authors: penson rt. Gynecol Oncol. 2001 May;81(2):206-12. doi: 10.1006/gyno.2000.5980. Gynecol Oncol. 2001. PMID: 11330951

6

A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.

Penson RT, Supko JG, Seiden MV, Fuller AF, Berkowitz RS, Goodman A, Campos SM, MacNeill KM, Cook S, Matulonis UA. Penson RT, et al. Cancer. 2001 Sep 1;92(5):1156-67. doi: 10.1002/1097-0142(20010901)92:5<1156::aid-cncr1434>3.0.co;2-g. Cancer. 2001. PMID: 11571729 Clinical Trial.

7

Attitudes to chemotherapy in patients with ovarian cancer.

Penson RT, Dignan F, Seiden MV, Lee H, Gallagher CJ, Matulonis UA, Olson K, Gibbens I, Gore ME. Penson RT, et al. Gynecol Oncol. 2004 Aug;94(2):427-35. doi: 10.1016/j.ygyno.2004.05.034. Gynecol Oncol. 2004. PMID: 15297184

8

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours.

Penson RT, Seiden MV, Matulonis UA, Appleman LJ, Fuller AF, Goodman A, Campos SM, Clark JW, Roche M, Eder JP. Penson RT, et al. Br J Cancer. 2005 Jul 11;93(1):54-9. doi: 10.1038/sj.bjc.6602671. Br J Cancer. 2005. PMID: 15986034 Free PMC article. Clinical Trial.

9

A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.

Seiden MV, Gordon AN, Bodurka DC, Matulonis UA, Penson RT, Reed E, Alberts DS, Weems G, Cullen M, McGuire WP 3rd. Seiden MV, et al. Among authors: penson rt. Gynecol Oncol. 2006 Apr;101(1):55-61. doi: 10.1016/j.ygyno.2005.09.036. Epub 2005 Nov 2. Gynecol Oncol. 2006. PMID: 16260029 Clinical Trial.

10

A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.

Penson RT, Campos SM, Seiden MV, Krasner C, Fuller AF Jr, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare. Penson RT, et al. Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1035-41. doi: 10.1111/j.1525-1438.2005.00482.x. Int J Gynecol Cancer. 2005. PMID: 16343179 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page